Episurf Medical

Episurf Medical (Nasdaq: EPIS B) today announces that Annette Brodin Rampe has, at her own request, resigned from her position as a member of the Board of Directors of Episurf Medical AB due to personal reasons. Annette Brodin Rampe has served as a member of Episurf Medical's Board since 2021.

"On behalf of the Board, I would like to thank Annette for her valuable contributions over the years," says Ulf Grunander, Chairman of the Board, Episurf Medical.

For more information, please contact:

Katarina Flodström, CEO, Episurf Medical
Tel: +46 707 38 35 70
Email: katarina.flodstrom@episurf.com

Pål Ryfors, acting CFO, Episurf Medical
Tel: +46 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical's Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.

The information was submitted for publication, through the agency of the above contact person, at 22:00 CEST on October 12, 2025.